Hu_2023_Front.Neurosci_17_1117584

INTRODUCTION: Epidemiological studies show that women have a higher prevalence of Alzheimer's disease (AD) than men. Peripheral estrogen reduction during aging in women is proposed to play a key role in this sex-associated prevalence, however, the underlying mechanism remains elusive. We previously found that transcription factor early growth response-1 (EGR1) significantly regulates cholinergic function. EGR1 stimulates acetylcholinesterase (AChE) gene expression and is involved in AD pathogenesis. We aimed to investigate whether the triple-transgenic AD (3xTg-AD) mice harboring PS1 (M146V) , APP (Swe) , and Tau (P301L) show sex differences in beta-amyloid (Abeta) and hyperphosphorylated tau (p-Tau), the two primary AD hallmarks, and how local 17beta-estradiol (E2) may regulate the expression of EGR1 and AChE. METHODS: We first sacrificed male and female 3xTg-AD mice at 3-4, 7-8, and 11-12 months and measured the levels of Abeta, p-Tau, EGR1, and AChE in the hippocampal complex. Second, we infected SH-SY5Y cells with lentivirus containing the amyloid precursor protein construct C99, cultured with or without E2 administration we measured the levels of extracellular Abeta and intracellular EGR1 and AChE. RESULTS: Female 3xTg-AD mice had higher levels of Abeta compared to males, while no p-Tau was found in either group. In SH-SY5Y cells infected with lentivirus containing the amyloid precursor protein construct C99, we observed significantly increased extracellular Abeta and decreased expression of intracellular EGR1 and AChE. By adding E2 to the culture medium, extracellular Abeta(l-42) was significantly decreased while intracellular EGR1 and AChE expression were elevated. DISCUSSION: This data shows that the 3xTg-AD mouse model can be useful for studying the human sex differences of AD, but only in regards to Ap. Furthermore, in vitro data shows local E2 may be protective for EGR1 and cholinergic functions in AD while suppressing soluble Abeta(1-42) levels. Altogether, this study provides further in vivo and in vitro data supporting the human epidemiological data indicating a higher prevalence of AD in women is related to changes in brain estrogen levels.